TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Gilead Sciences Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
42,075
|
43,564
|
31,556 |
| Financial expenses |
0
|
0
|
30 |
| Earnings before taxes |
2,043
|
2,082
|
1,104 |
| EBITDA |
1,878
|
1,925
|
1,188 |
| Total assets |
43,764
|
49,840
|
45,917 |
| Current assets |
43,284
|
49,304
|
45,335 |
| Current liabilities |
7,116
|
10,156
|
8,117 |
| Equity capital |
17,337
|
16,293
|
14,723 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
57
|
58
|
54 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
39.6%
|
32.7%
|
32.1% |
| Turnover per employee |
738
|
751
|
584 |
| Profit as a percentage of turnover |
4.9%
|
4.8%
|
3.5% |
| Return on assets (ROA) |
4.7%
|
4.2%
|
2.5% |
| Current ratio |
608.3%
|
485.5%
|
558.5% |
| Return on equity (ROE) |
11.8%
|
12.8%
|
7.5% |
| Change turnover |
-8
|
11,917
|
1,827 |
| Change turnover % |
0%
|
38%
|
6% |
| Chg. No. of employees |
-1
|
4
|
4 |
| Chg. No. of employees % |
-2%
|
7%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.